Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
UPDATE: Cantor Fitzgerald Starts Metalla Royalty & Streaming Ltd. (MTA:CN) (MTA) at Buy
-
Companies with NDRs 6/03
-
European shares rally on improving data, insurers jump
-
Freddie Mac Prices $257 Million Multifamily K-Deal, K-J29
-
Marinus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Arena Pharma (ARNA) PT Raised to $88 at Cantor Fitzgerald
-
Pre-Open Stock Movers 06/02: (MGI) (WU) (SWBI) Higher; (PUMP) (INVH) (GH) Lower (more...)
-
Regeneron Pharma (REGN) PT Jumps More than 50% to $624 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Assumes Pacific Biosciences of California (PACB) at Overweight
-
After-Hours Stock Movers 6/1: (MGI) (KLDO) (XGN) HIGHER; (PUMP) (INVH) (GH) LOWER (more...)
-
Cantor Fitzgerald Downgrades Evolent Health (EVH) to Neutral
-
Cantor Fitzgerald Assumes Exagen (XGN) at Overweight
-
Pfizer (PFE) Sells Off on Ibrance Miss, Cantor Fitzgerald Believes Miss Isn't Enough to Derail 2020 Ests
-
Companies with NDRs 6/01
-
Arvinas (ARVN) Weakness a Buying Opportunity - Cantor Fitzgerald
-
Marinus Pharma (MRNS) Prices 16M Share Common Offering at $2.50/Sh
-
Repay Holdings Corporation (RPAY) Prices 8M Share Common Offering at $20/Sh
-
Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
REPAY Announces Pricing of Public Offering of Common Stock
-
Marinus Pharma (MRNS) to Offer Common Stock
-
Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Legg Mason And ClearBridge Investments Launch Semi-Transparent ETF Using Precidian Investments' Innovative ActiveShares® Technology
-
Companies with NDRs 5/28
-
Companies with NDRs 5/27
-
SelectQuote Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
-
Evofem Biosciences Inc (EVFM) PT Raised to $15 at Cantor Fitzgerald
-
Companies with NDRs 5/26
-
Evofem Biosciences Inc (EVFM) Phexxi Approval Removes Overhang - Cantor Fitzgerald
-
Good News Likely Driving Evolus (EOLS) Stock Higher, But Not Clear What It Is - Cantor Fitzgerald
-
Companies with NDRs 5/22
-
ContraFect (CFRX) Prices 11.797M Share & Warrants Offering at $4.90/Sh
-
ContraFect Corporation Prices Approximately $52.5 Million Public Offering of Common Stock and Warrants
-
ContraFect (CFRX) Announces Proposed Public Offering of Common Stock and Warrants
-
ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants
-
Aurora Cannabis (ACB:CN) (ACB) PT Raised to Cdn$27 at Cantor Fitzgerald; Positive on Reliva Deal
-
Companies with NDRs 5/21
-
SelectQuote Inc. (SLQT) Prices 28.5M Share IPO at $20/Sh
-
European stocks hit by U.S.-China tensions, recovery doubt
-
SelectQuote Announces Pricing of Initial Public Offering
-
Trulieve Cannabis Corp (TRUL:CN) (TCNNF) PT Raised to $50 at Cantor Fitzgerald
-
Great Panther Announces Closing of US$16.1 Million Bought Deal Financing
-
Companies with NDRs 5/20
-
Pre-Open Stock Movers 05/19: (ABUS) (DVAX) (AAP) Higher; (BLPH) (GMDA) (GOOS) Lower (more...)
-
Companies with NDRs 5/19
-
After-Hours Stock Movers 05/18: (ABUS) (DAC) (BIDU) Higher; (BLPH) (GMDA) (GOSS) Lower (more...)
-
Cantor Fitzgerald Starts Rapt Therapeutics (RAPT) at Overweight
-
Johnson & Johnson to Provide Webcast Fireside Chat on Clinical Data to be Presented at the American Society of Clinical Oncology and the Janssen Oncology Strategy and Portfolio
-
cbdMD Inc. (YCBD) PT Raised to $1.80 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Coeur d'Alene Mines (CDE) at Buy (Earlier)

